Evidence map›Paper›PMID 27798695›Full record

ArticlePloS one2016

Genotypic and Phenotypic Characterization of Stenotrophomonas maltophilia Strains from a Pediatric Tertiary Care Hospital in Serbia.

Haowa Madi, Jovanka Lukić, Zorica Vasiljević, Marjan Biočanin, Milan Kojić, Branko Jovčić, Jelena Lozo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Antibiotic Resistance and Virulence Factors in Clinical Isolates ofInternational journal of microbiology · 2024
    Article
  6. Frontiers in microbiology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Comparative genomics analysis ofFrontiers in cellular and infection microbiology · 2023
    Article
  11. Clinical challenges treatingJAC-antimicrobial resistance · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genes · 2021
    Review
  17. Article
  18. Biofilm Formation amongMicroorganisms · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Haowa MadiUniversity of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.
Jovanka LukićUniversity of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.
Zorica VasiljevićInstitute for Mother and Child Health Care of Serbia "Dr Vukan Čupić", Belgrade, Serbia.
Marjan BiočaninUniversity of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.
Milan KojićUniversity of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.
Branko JovčićUniversity of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.
Jelena LozoUniversity of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia.
University of Belgrade · RSInstitute of Molecular Genetics and Genetic EngineeringInstitute of Public Health of Serbia · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStenotrophomonas maltophilia is an environmental bacterium and an opportunistic pathogen usually associated with healthcare-associated infections, which has recently been recognized as a globally multi-drug resistant organism. The aim of this study was genotyping and physiological characterization of Stenotrophomonas maltophilia isolated in a large, tertiary care pediatric hospital in Belgrade, Serbia, hosting the national reference cystic fibrosis (CF) center for pediatric and adult patients.

methodsWe characterized 42 strains of cystic fibrosis (CF) and 46 strains of non-cystic fibrosis (non-CF) origin isolated from 2013 to 2015 in order to investigate their genetic relatedness and phenotypic traits. Genotyping was performed using sequencing of 16S rRNA gene, Pulse Field Gel Electrophoresis (PFGE) and Multi locus sequencing typing (MLST) analysis. Sensitivity to five relevant antimicrobial agents was determined, namely trimethoprim/sulfamethoxazole (TMP/SMX), chloramphenicol, ciprofloxacin, levofloxacin and tetracycline. Surface characteristics, motility, biofilm formation and adhesion to mucin were tested in all strains. Statistical approach was used to determine correlations between obtained results.

resultsMost of the isolates were not genetically related. Six new sequence types were determined. Strains were uniformly sensitive to all tested antimicrobial agents. The majority of isolates (89.8%) were able to form biofilm with almost equal representation in both CF and non-CF strains. Swimming motility was observed in all strains, while none of them exhibited swarming motility. Among strains able to adhere to mucin, no differences between CF and non-CF isolates were observed.

conclusionsHigh genetic diversity among isolates implies the absence of clonal spread within the hospital. Positive correlation between motility, biofilm formation and adhesion to mucin was demonstrated. Biofilm formation and motility were more pronounced among non-CF than CF isolates.

Indexed as

GenotypePhenotypeTertiary Care CentersAdolescentAdultAnti-Bacterial AgentsBacterial AdhesionBiofilmsChildChild, PreschoolCross InfectionFemaleGram-Negative Bacterial InfectionsHumansMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsRNA, Ribosomal, 16S

Identifiers

PMID27798695
PMCPMC5087882
OpenAlexW2545349444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.